OraSure Technologies Inc
Change company Symbol lookup
Select an option...
OSUR OraSure Technologies Inc
MRDY Mobile Ready Entertainment Corp
MANT ManTech International Corp
LXFR Luxfer Holdings PLC
SYZLF Sylogist Ltd
BSX Boston Scientific Corp
PNGAY Ping An Insurance Group Co of China Ltd
GLOP GasLog Partners LP
AGNC Agnc Investment Corp
TSOEX TIAA-CREF Social Choice International Equity Fund (Retirement)
Go

Health Care : Health Care Equipment & Supplies | Small Cap Blend
Company profile

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection devices, and medical devices. DNAG or molecular collection systems business consists primarily of the development, manufacture and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing.

Price
Delayed
$10.56
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)

Today's volume of 4 shares is on pace to be much lighter than OSUR's 10-day average volume of 1,337,196 shares.

4

OraSure Technologies to Present at the Jefferies Virtual Healthcare Conference

7:00 am ET May 28, 2021 (Globe Newswire) Print

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference. The conference will be simultaneously webcast over the Internet.

Dr. Tang is scheduled to speak on June 4, 2021, at 10:30 AM EDT. The live webcast and a replay of the presentation can be accessed by going to OraSure Technologies' web site, www.orasure.com and clicking on the Investor Info link. A replay of the webcast will be available on OraSure Technologies' web site for 14 days. Alternatively, you can access the live webcast of the presentation here.

About OraSure Technologies

OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. OraSure, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure's portfolio of products is sold globally to clinical laboratories, hospitals, physician's offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com.

Company contacts:

Scott Gleason

SVP of IR and Corp. Communications

484-425-0588

sgleason@orasure.com

Jeanne Mell

VP Corporate Communications

484-353-1575

media@orasure.com

www.orasure.com

https://ml.globenewswire.com/media/65692861-ef8b-490e-b730-7449593e438f/small/orasure-technologies-inc-logo.jpg

https://ml.globenewswire.com/media/65692861-ef8b-490e-b730-7449593e438f/small/orasure-technologies-inc-logo.jpg

comtex tracking

COMTEX_387449969/2010/2021-05-28T07:00:02

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.